203 related articles for article (PubMed ID: 35182476)
1. EBF1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells.
Zhou Y; Petrovic J; Zhao J; Zhang W; Bigdeli A; Zhang Z; Berger SL; Pear WS; Faryabi RB
Mol Cell; 2022 Mar; 82(5):1003-1020.e15. PubMed ID: 35182476
[TBL] [Abstract][Full Text] [Related]
2. Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL.
Antoszewski M; Fournier N; Ruiz Buendía GA; Lourenco J; Liu Y; Sugrue T; Dubey C; Nkosi M; Pritchard CEJ; Huijbers IJ; Segat GC; Alonso-Moreno S; Serracanta E; Belver L; Ferrando AA; Ciriello G; Weng AP; Koch U; Radtke F
Blood; 2022 Apr; 139(16):2483-2498. PubMed ID: 35020836
[TBL] [Abstract][Full Text] [Related]
3. ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.
Thoms JA; Birger Y; Foster S; Knezevic K; Kirschenbaum Y; Chandrakanthan V; Jonquieres G; Spensberger D; Wong JW; Oram SH; Kinston SJ; Groner Y; Lock R; MacKenzie KL; Göttgens B; Izraeli S; Pimanda JE
Blood; 2011 Jun; 117(26):7079-89. PubMed ID: 21536859
[TBL] [Abstract][Full Text] [Related]
4. A Prion-like Domain in Transcription Factor EBF1 Promotes Phase Separation and Enables B Cell Programming of Progenitor Chromatin.
Wang Y; Zolotarev N; Yang CY; Rambold A; Mittler G; Grosschedl R
Immunity; 2020 Dec; 53(6):1151-1167.e6. PubMed ID: 33159853
[TBL] [Abstract][Full Text] [Related]
5. EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.
Somasundaram R; Jensen CT; Tingvall-Gustafsson J; Åhsberg J; Okuyama K; Prasad M; Hagman JR; Wang X; Soneji S; Strid T; Ungerbäck J; Sigvardsson M
Blood; 2021 Jun; 137(22):3037-3049. PubMed ID: 33619557
[TBL] [Abstract][Full Text] [Related]
6. EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.
Ramamoorthy S; Kometani K; Herman JS; Bayer M; Boller S; Edwards-Hicks J; Ramachandran H; Li R; Klein-Geltink R; Pearce EL; Grün D; Grosschedl R
Genes Dev; 2020 Nov; 34(21-22):1503-1519. PubMed ID: 33004416
[No Abstract] [Full Text] [Related]
7. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
Yang L; Chen F; Zhu H; Chen Y; Dong B; Shi M; Wang W; Jiang Q; Zhang L; Huang X; Zhang MQ; Wu H
Nat Commun; 2021 Jun; 12(1):3708. PubMed ID: 34140506
[TBL] [Abstract][Full Text] [Related]
8. Pioneering Activity of the C-Terminal Domain of EBF1 Shapes the Chromatin Landscape for B Cell Programming.
Boller S; Ramamoorthy S; Akbas D; Nechanitzky R; Burger L; Murr R; Schübeler D; Grosschedl R
Immunity; 2016 Mar; 44(3):527-541. PubMed ID: 26982363
[TBL] [Abstract][Full Text] [Related]
9. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.
Yashiro-Ohtani Y; Wang H; Zang C; Arnett KL; Bailis W; Ho Y; Knoechel B; Lanauze C; Louis L; Forsyth KS; Chen S; Chung Y; Schug J; Blobel GA; Liebhaber SA; Bernstein BE; Blacklow SC; Liu XS; Aster JC; Pear WS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4946-53. PubMed ID: 25369933
[TBL] [Abstract][Full Text] [Related]
10. Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis.
Welsh SJ; Churchman ML; Togni M; Mullighan CG; Hagman J
Leukemia; 2018 Jan; 32(1):38-48. PubMed ID: 28555080
[TBL] [Abstract][Full Text] [Related]
11. Tnpo3 enables EBF1 function in conditions of antagonistic Notch signaling.
Bayer M; Boller S; Ramamoothy S; Zolotarev N; Cauchy P; Iwanami N; Mittler G; Boehm T; Grosschedl R
Genes Dev; 2022 Aug; 36(15-16):901-915. PubMed ID: 36167471
[TBL] [Abstract][Full Text] [Related]
12. Developmentally regulated higher-order chromatin interactions orchestrate B cell fate commitment.
Boya R; Yadavalli AD; Nikhat S; Kurukuti S; Palakodeti D; Pongubala JMR
Nucleic Acids Res; 2017 Nov; 45(19):11070-11087. PubMed ID: 28977418
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia.
Kloetgen A; Thandapani P; Ntziachristos P; Ghebrechristos Y; Nomikou S; Lazaris C; Chen X; Hu H; Bakogianni S; Wang J; Fu Y; Boccalatte F; Zhong H; Paietta E; Trimarchi T; Zhu Y; Van Vlierberghe P; Inghirami GG; Lionnet T; Aifantis I; Tsirigos A
Nat Genet; 2020 Apr; 52(4):388-400. PubMed ID: 32203470
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia.
Iglesias P; Puller AC; Seoane M; Spohn M; Raasch S; Klokow M; Müller J; Burkhardt L; Indenbirken D; Horstmann MA
Blood Adv; 2021 Mar; 5(5):1209-1223. PubMed ID: 33646306
[TBL] [Abstract][Full Text] [Related]
15. RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.
Cheng JX; Chen L; Li Y; Cloe A; Yue M; Wei J; Watanabe KA; Shammo JM; Anastasi J; Shen QJ; Larson RA; He C; Le Beau MM; Vardiman JW
Nat Commun; 2018 Mar; 9(1):1163. PubMed ID: 29563491
[TBL] [Abstract][Full Text] [Related]
16. Non-coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate.
Isoda T; Moore AJ; He Z; Chandra V; Aida M; Denholtz M; Piet van Hamburg J; Fisch KM; Chang AN; Fahl SP; Wiest DL; Murre C
Cell; 2017 Sep; 171(1):103-119.e18. PubMed ID: 28938112
[TBL] [Abstract][Full Text] [Related]
17. Defining B Cell Chromatin: Lessons from EBF1.
Boller S; Li R; Grosschedl R
Trends Genet; 2018 Apr; 34(4):257-269. PubMed ID: 29336845
[TBL] [Abstract][Full Text] [Related]
18. New genetic abnormalities and treatment response in acute lymphoblastic leukemia.
Meijerink JP; den Boer ML; Pieters R
Semin Hematol; 2009 Jan; 46(1):16-23. PubMed ID: 19100364
[TBL] [Abstract][Full Text] [Related]
19. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.
Heltemes-Harris LM; Willette MJ; Ramsey LB; Qiu YH; Neeley ES; Zhang N; Thomas DA; Koeuth T; Baechler EC; Kornblau SM; Farrar MA
J Exp Med; 2011 Jun; 208(6):1135-49. PubMed ID: 21606506
[TBL] [Abstract][Full Text] [Related]
20. TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.
Smith C; Goyal A; Weichenhan D; Allemand E; Mayakonda A; Toprak U; Riedel A; Balducci E; Manojkumar M; Pejkovska A; Mücke O; Sollier E; Bakr A; Breuer K; Lutsik P; Hermine O; Spicuglia S; Asnafi V; Plass C; Touzart A
Haematologica; 2023 May; 108(5):1259-1271. PubMed ID: 36632736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
